{"disease":{"id":"avian-influenza-a-virus","name":"avian influenza a virus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06842173","title":"Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT07275060","title":"Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":312,"lead_sponsor_name":"Canadian Immunization Research Network","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}